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Introduction {#sec001}
============

Invasive aspergillosis (IA) is a fatal disease caused by *Aspergillus* species that occurs mainly in immunocompromised patients \[[@pone.0229561.ref001]\]. Common species that cause IA include *Aspergillus fumigatus*, *A*. *flavus*, *A*. *terreus*, and *A*. *niger*. Recently, global studies have reported "cryptic species" such as *A*. *lentulus*, *A*. *udagawae*, and *A*. *tubingensis* and increasing antifungal resistance. Above all, rapid and accurate fungal diagnosis is important, as the morbidity and mortality of IA remain high, and diagnosis and treatment impart a significant economic burden \[[@pone.0229561.ref002]--[@pone.0229561.ref005]\].

The method of *Aspergillus* species identification includes morphologic identification of fungi through culture and molecular identification via the polymerase chain reaction (PCR) \[[@pone.0229561.ref005], [@pone.0229561.ref006]\]. The former method is currently the gold standard; however, its use can depend largely on clinical specimen quality and the proficiency of the microbiology test personnel \[[@pone.0229561.ref006], [@pone.0229561.ref007]\] The latter method, molecular identification of filamentous ascomycetes, is mainly conducted through sequence analysis of the internal transcribed spacer (*ITS*) region, and *β-tubulin* (*benA*) and *calmodulin* (*CaM*) genes are also used for cryptic species-level identification \[[@pone.0229561.ref002], [@pone.0229561.ref008], [@pone.0229561.ref009]\]. However sequencing-based identification is time-consuming, as it takes 5--17 days to reach the final diagnosis; specifically, it takes 3--14 days to produce conidia following fungal culture from the clinical sample, followed by an additional 2--3 days to extract DNA from the conidia and obtain sequencing analysis results \[[@pone.0229561.ref010], [@pone.0229561.ref011]\].

Therefore, to take advantage and overcome the shortcomings of the multi-step molecular diagnosis method, there have been many efforts to explore new diagnostic approaches \[[@pone.0229561.ref006]--[@pone.0229561.ref014]\]. In this study, we aimed to develop a method for rapid molecular identification by using a multiplex platform that allows for quantitative analysis of major *Aspergillus* sections and rapid detection of azole resistance.

Material & method {#sec002}
=================

Fungal isolates and culture {#sec003}
---------------------------

The fungal isolates used in this study were representative strains of clinical and environmental isolates stored anonymously, and standard strains including *A*. *fumigatus* (ATCC 16424; American Type Culture Collection, Manassas, VA, USA), *A*. *terreus* (ATCC 10690), *A*. *flavus* (ATCC 16883), and *A*. *niger* (ATCC 16888) \[[@pone.0229561.ref002], [@pone.0229561.ref015]\]. The representative *Aspergillus* isolates were selected for each sequence type according to *benA* and *cyp51A* sequencing results. The *Aspergillus* isolates used in this study included 20 strains of *A*. *fumigatus*, 2 strains of *A*. *lentulus*, 1 strain of *A*. *turcosus*, 1 strain of *A*. *udagawae*, 2 strains of *A*. *luchuensis*, 11 strains of *A*. *awamori*, 11 strains of *A*. *niger*, 12 strains of *A*. *tubingensis*, 4 strains of *A*. *flavus*, 1 strain of *A*. *nidulans*, 2 strains of *A*. *sydowii*, 3 strains of *A*. *terreus*, and 1 strain of *A*. *subramanianii*, which were registered to GenBank in our previous study \[[@pone.0229561.ref002]\]. In addition, 38 non-*Aspergillus* filamentous ascomycetes (No. 1--38), 1 non-filamentous ascomycetes (No. 39), and 8 non-ascomycetes molds (No. 40--47) were used to measure the specificity of the developed molecular identification method ([S1 Table](#pone.0229561.s004){ref-type="supplementary-material"}). Fungal isolates were cultured using Sabouraud's dextrose agar medium (Becton-Dickinson Labware, Franklin Lakes, NJ, USA) in an incubator at 35°C for 1--10 days. Conidia or hyphae were harvested for genomic DNA (gDNA) extraction using 0.85% NaCl with 0.05% Tween 20. Pellets of conidia or hyphae were stored at −80°C until DNA extraction. The Institutional Review Board of Seoul St. Mary's Hospital approved the research protocol of this study (KC16SISI0307) and waived informed consent for use of fungal isolates stored anonymized.

DNA extraction and purification {#sec004}
-------------------------------

To optimize DNA extraction from fungal isolates, the following steps were conducted. In brief, the hyphae pellets stored in the deep freezer were placed in 500 μL Trizol reagent (Invitrogen, Carlsbad, CA, USA), and the conidia pellets were placed in 500 μL of yeast cell lysis solution (MasterPure^™^ Yeast DNA Purification Kit, Epicentre, Madison, WI, USA); subsequently, the pellets were subjected to two freeze-thaw cycles. After adding RNase A (Epicentre), incubating at 5 min in room temperature. And bead-beating (1.0 mm zirconium beads; Sigma-Aldrich, St. Louis, MO, USA) was repeated 3--5 times at 12,500 rpm for 5 min and cooled on ice at 1 min in between time. Then, the supernatant was obtained after centrifugation (\>12,000 × *g*, 4°C, 5 min). In the method using Trizol reagent, chloroform (Sigma-Aldrich) was added and reacted at room temperature for 5 min; in the method using yeast cell lysis solution, MPC protein precipitation reagent (Epicentre) was added and vortexed. The sample was centrifuged (\>12,000 × *g*, 4°C, 15 min) to collect the supernatant, which was then treated with isopropanol (Sigma-Aldrich). A QIAamp DNA Mini spin column (Qiagen, Hildren, Germany) was used to purify fungal DNA. The extracted DNA concentration was measured using Quant-iT^™^ PicoGreen^™^ dsDNA Reagent (Invitrogen) according to the manufacturer's protocol. In the case that further DNA purification was required, the DNeasy PowerClean Pro CleanUp Kit (Qiagen) was used according to the manufacturer's protocol. The extracted DNA was stored at −20°C before the next experiment.

Design of primers and probes {#sec005}
----------------------------

In this study, the sequences of clinical and environmental *Aspergillus* isolates were analyzed to design new primers for amplifying the relatively short sequence of exons 5--6 of the *benA* gene (for *A*. *fumigatus* AF293 strain *benA* gene, GCA_000002655.1_ASM265v1, locus_tag = AFUA_1G10910, location no. 544--803) ([Table 1](#pone.0229561.t001){ref-type="table"}). The nucleotide sequence of *Aspergillus* isolates was analyzed using MegAlign Pro 15 (DNASTAR, Madison, WI, USA). A probe that could detect filamentous ascomycetes was designed in exon 5, and other probes were designed for the intron between exons 5 and 6 ([S1 Fig](#pone.0229561.s001){ref-type="supplementary-material"}). For the amplification and simultaneous detection of the *benA* target, dimer and hairpin formation of primers and probes was measured, and heterodimer delta G values ranged from −3.6 to −8.9 kcal/mol of five probe.

10.1371/journal.pone.0229561.t001

###### Nucleic acid sequences of biomarkers (primers or/and probes set) designed for multiplex identification in this study.

![](pone.0229561.t001){#pone.0229561.t001g}

  PCR                              Target species              Primers / probes                                                                Sequence (5′ → 3′)                                 Target loci                  Product size    Reference
  -------------------------------- --------------------------- ------------------------------------------------------------------------------- -------------------------------------------------- ---------------------------- --------------- ---------------
  Multiplex real-time PCR primer   *Aspergillus spp*.          benA F3                                                                         `TCGGTGTAGTGACCCTTGG`                              *β-tubulin (benA)*           254 \~ 272 bp   In this study
  benA R2                          `GCTGGAGCGYATGAACGTCT`                                                                                                                                                                                      
  *A*. *tubingensis*               Tubcyp 1F46                 `CTCGTTGCGATAGTCTTKAATGT`                                                       *cyp51A*                                           263 bp                                       
  Tubcyp 1R308                     `GCCCAAGTATACGGTKGTCTTTT`                                                                                                                                                                                   
  *A*. *fumigatus*                 TR F1                       `TAATCGCAGCACCACTTCAG`                                                          WT[^‡^](#t001fn002){ref-type="table-fn"}: 111 bp   \[[@pone.0229561.ref016]\]                   
  TR R1                            `AGGGTGTATGGTATGCTGGAA`     TR34 : 145 bp                                                                   In this study                                                                                   
  Hydrolysis probe                 Ascomycetes                 Asco 1F9                                                                        `6-FAM-AVACGAAGTTGTCGGGRC-TAMRA`                   *β-tubulin (benA)*           18 bp           In this study
  Section *Fumigati*               Fumi 1R2                    `HEX-CGGCAACATCTCACGATCTGACTCGC-BHQ1`                                           26 bp                                                                                           
  Section *Nigri*                  Nig 1R26                    `6-FAM-ACTTCAGCAGGCTAGCGGTAACAAGT-TAMRA`                                        26 bp                                                                                           
  Section *Flavi*                  Flavi 1F18                  `HEX-CGGTCAGGAGTTGCAAAGCGTTTTCA-BHQ1`                                           26 bp                                                                                           
  Section *Terrei*                 Terrei 1R29                 `6-FAM-ACCATCCTGGGACAGATTCTYCACGC-TAMRA`                                        26 bp                                                                                           
  *A*. *tubingensis*               Tubcyp 201                  `6-FAM-GTCAGYCACTGTCCATATGCGATTG-TAMRA`[^†^](#t001fn001){ref-type="table-fn"}   *cyp51A*                                           25 bp                                        

^†^ The underlined area is a probe synthesized by LNA.

^‡^ Wild type

We designed two staged probe sets: For the first stage, primer and probe sequences specific to four major *Aspergillus* sections (*Fumigati*, *Nigri*, *Terrei*, and *Flavi*) were designed, and a control probe sequence was also determined to identify filamentous ascomycetes. Based on the analysis using the OligoAnalyzer web program (<https://sg.idtdna.com/pages/tools/oligoanalyzer>) for each primer and probe, the final biomarkers were developed for multiplex molecular identification ([Table 1](#pone.0229561.t001){ref-type="table"}). The specificity of the synthesized probe was evaluated using BLASTn (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>), and the presence of cross-reactions between sections was identified. For the second stage, primers and probes specific for both TR mutations in the *cyp51A* promoter and *A*. *tubingensis* were designed ([Table 1](#pone.0229561.t001){ref-type="table"}). The *A*. *tubingensis* probe was designed for a specific sequence in the *cyp51A* gene using locked nucleic acid to increase specificity. Promoter mutation was detected by melting temperature analysis instead of the probe detection method.

Synthesized the control DNA {#sec006}
---------------------------

More controls need more wells. In clinical settings, more control leads to fewer test samples, especially in quantitative analysis. Therefore, we designed a synthesized control including all probes (5 probes). At first, we aligned each consensus sequence of *benA* in *Aspergillus* species ([S1 Fig](#pone.0229561.s001){ref-type="supplementary-material"}). We used *benA* sequence of *A*. *fumigatus* as the template and designed to have each probe sequence (conserved probe of filamentous ascomycetes, *Fumigati*, *Nigri*, *Flavi*, and *Terrei*) ([Table 2](#pone.0229561.t002){ref-type="table"}). And then, the designed DNA was synthesized genetically (Bionics Corporation, Seoul). We cloned it into the pUC57 plasmid, and it was transformed into *Escherichia coli* (*E*. *coli*) BL21 strain. Plasmid DNA of transformants was extracted, tested for the multiplex, and used as control DNA.

10.1371/journal.pone.0229561.t002

###### Positive control nucleic acid sequences for *Aspergillus* real-time PCR assays.

![](pone.0229561.t002){#pone.0229561.t002g}

  ----------------------------------------------------------------------------------------------------------------------------------------
  Oligo                                         DNA Sequence (5′ → 3′)
  --------------------------------------------- ------------------------------------------------------------------------------------------
  *Aspergillus* Positive Control DNA (276 bp)   `ATCGTAAGCTTTCGGTGTAGTGACCCTTGGCCCAGCCGAAGACGAAGTTGTCGGGACGGACGGTCAGGAGTTGCAAAGCG`\
                                                            benA F3 primer                Asco 1F9 probe               Flavi 1F18 probe\
                                                `TTTTCAGCACGGACAACTCAGGGACGGTGTGATCTAACCTCATGGTACGCGTGGAGAATCTGTCCCAGGATGGTAGAACGG`\
                                                                  Terrei 1R29 probe\
                                                `CACGAGGTAGCGAGTCAGATCGTGAGATGTTGCCGAAATAGTATAAATCAAGAGACTTGTTACCGCTAGCCTGCTGAAGTAA`\
                                                             Fumi 1R2 probe                 Nig 1R26 probe\
                                                `ATAGACGTTCATGCGCTCCAGCGAGCTCATCGT`\
                                                       benA R2 primer

  ----------------------------------------------------------------------------------------------------------------------------------------

Qualitative and quantitative analysis by multiplex real-time PCR {#sec007}
----------------------------------------------------------------

Qualitative and quantitative analyses were conducted using the LightCycler® 480 Probes Master Kit (Roche, Basel, Switzerland) and Roche LightCycler® 480 Instrument II (Roche). The primer and probe concentrations used in the experiment were 0.5 μM and 0.1 μM, respectively. The amplification process was conducted as follows: 10 min of pre-denaturation at 95°C followed by 40 cycles of denaturation at 95°C for 25 s, annealing at 58°C for 30 s, and extension at 72°C for 35 s. For quantitative analysis, 4 ng fungal gDNA and 4 pg *Aspergillus* positive control DNA were each subjected to 10-fold serial dilutions to reach 4 fg/μL and 4 ag/μL, respectively. Melting peak analysis was conducted using the LightCycler® 480 SYBR Green I Master Kit (Roche) and Roche LightCycler® 480 Instrument II (Roche).

The results were analyzed using LightCycler® 480 Software version 1.5.0 SP3 (Roche). The quantification cycle (Cq) was calculated automatically by the program based on curve fitting to the baseline curve subtraction. A standard curve was obtained using the measured results, and the slope value, mean Cq value (MCq), and standard deviation (SD) were calculated. The amplification efficiency (Efficiency, E \[%\]) was calculated by the following equation: \[10^(−1/(slope))^ − 1\] × 100. Sensitivity analysis of the developed identification method was conducted using the limit of detection (LOD) and limit of quantitation (LOQ). The LOD was set to the minimum value detected above 95% of analysis results (\<5% false negative result). The LOQ was determined to be a value of MCq − (2 × SD) below 35 \[[@pone.0229561.ref017], [@pone.0229561.ref018]\].

All experiments were conducted in accordance with the "Minimum Information for the Publication of Real-Time Quantitative PCR Experiments" (MIQE) guidelines \[[@pone.0229561.ref019], [@pone.0229561.ref020]\]. In addition, the experiment was conducted in a biosafety cabinet in an area separate from the DNA extraction area to prevent contamination from aerosol and carryover. To remove contaminants on the surface, 1.5% sodium hypochlorite (NaOCl) was used, followed by 70% EtOH. The experiment was conducted using filter tips (TipOne; StarLab, Hamburg, Germany) after removing all possible contaminants.

Inhibition testing {#sec008}
==================

The SPUD assay was used as an exogenous amplification control \[[@pone.0229561.ref019]\]. The SPUD inhibition assay results generate the expected baseline Cq value for the SPUD amplicon and use it as the basis for the uninhibited assay. Based on this, Cq values exceeding 1 cycle or more of other DNA amplifications indicate the presence of a PCR inhibitor. The reaction of each qPCR was carried out using the LightCycler 480 SYBR Green I Master Kit (Roche). The SPUD plasmid DNA was 1.3 X 10^5^ genome copy number (copy/μL) and the primer 0.5 μM. And sample extract was added 4ng gDNA. Thermal cycling conditions were 10 min of pre-denaturation at 95° C followed by 40 cycles of denaturation at 95° C for 10 s, annealing at 60° C for 10 s, and extension at 72° C for 20 s.

Results {#sec009}
=======

Qualitative analysis to determine probe specificity {#sec010}
---------------------------------------------------

Multiplex real-time PCR of 118 fungal DNA samples showed that the probes specifically amplified the *Aspergillus* section as presented in [Table 3](#pone.0229561.t003){ref-type="table"}. No amplification was observed in non-*Aspergillus* isolates. 1 non-filamentous ascomycetes (No. 39), and 8 non-ascomycetes molds (No. 40\~47) showed no amplification of all primers and probes, including the Asco 1F9 probe. Further, the *Aspergillus* positive control DNA was amplified in all primers and probes designed for the first stage, and there was no interference between probes. For the second stage, real-time PCR was performed for 20 *A*. *fumigatus* (17 wild-type and 3 mutant strains), 2 *A*. *lentulus*, 1 *A*. *turcosus*, and 1 *A*. *udagawae* strains, and the melting peaks were analyzed. The melting temperature was 83.0 ± 0.3°C in *A*. *fumigatus* wild-type samples and 85.6 ± 0.6°C in mutant isolates with TR34 ([S2 Fig](#pone.0229561.s002){ref-type="supplementary-material"}). *Aspergillus* section *Fumigati* isolates were not amplified except for *A*. *fumigatus*. In addition, one primer pair (Tubcyp 1F46 and Tubcyp 1R308) and one probe (Tubcyp 201) designed to identify *A*. *tubingensis* from *Aspergillus* section *Nigri* were tested on 36 *Aspergillus* isolates of section *Nigri* in real-time PCR analysis. All 12 *A*. *tubingensis* isolates with different *cyp51A* sequence types were amplified ([Table 3](#pone.0229561.t003){ref-type="table"}); other isolates were not amplified.

10.1371/journal.pone.0229561.t003

###### Specific amplification of the designed probes.

![](pone.0229561.t003){#pone.0229561.t003g}

  Probe (n)    *Aspergillus* section   Non-*Aspergillus* (47)                                                
  ------------ ----------------------- ------------------------ -------------- -------------- -------------- --------------------------------------------------------
  Asco 1F9     24 / 24 (100%)          36 / 36 (100%)           4 / 4 (100%)   3 / 3 (100%)   4 / 4 (100%)   30 / 38[^†^](#t003fn001){ref-type="table-fn"} (63.82%)
  Fumi 1R2     24 / 24 (100%)          0 / 36 (0%)              0 / 4 (0%)     0 / 3 (0%)     0 / 4 (0%)     0 / 47 (0%)
  Nig 1R26     0 / 24 (0%)             36 / 36 (100%)           0 / 4 (0%)     0 / 3 (0%)     0 / 4 (0%)     0 / 47 (0%)
  Flavi 1F18   0 / 24 (0%)             0 / 36 (0%)              4 / 4 (100%)   0 / 3 (0%)     0 / 4 (0%)     0 / 47 (0%)
  Ter 1R29     0 / 24 (0%)             0 / 36 (0%)              0 / 4 (0%)     3 / 3 (100%)   0 / 4 (0%)     0 / 47 (0%)
  Tubcyp 201   0 / 24 (0%)             12 / 12 (100%)           0 / 4 (0%)     0 / 3 (0%)     0 / 4 (0%)     0 / 47 (0%)

^†^ Ratio of non-*Aspergillus* Filamentous ascomycetes

Probe sensitivity and efficiency measurement {#sec011}
--------------------------------------------

Quantitative analysis results of gDNA of major *Aspergillus* sections are shown in [Fig 1](#pone.0229561.g001){ref-type="fig"}. There was no interference during the amplification of two probes analyzed in the multiplex assay, and gDNA was amplified from 4 ng/μL to 40 fg/μL in all probes. Similarly, amplification occurred without interference in the positive control DNA, which was amplified from 4 pg/μL to 40 ag/μL in all probes. The standard curve obtained from plotting gDNA concentration on the X-axis and Cq value on the Y-axis yielded slope values, intercept values, and R^2^ --in the ranges of −3.2119 to −3.7230, 40.316 to 43.702, and 0.9979 to 0.9998, respectively. The amplification efficiency of each probe was found to be 89.8% \~ 104.8% in gDNA and 90.0% \~ 99.4% in Control DNA ([Table 4](#pone.0229561.t004){ref-type="table"}). The LOD and LOQ of gDNA in all probes was 40 fg/μL (1.0--1.2 × 10^0^ genome copies/μL) and 400 fg/μL (1.0--1.2 × 10^1^ genome copies/μL), respectively. For positive control DNA, all probes showed similar correlations and regression analysis results, as shown in [Table 5](#pone.0229561.t005){ref-type="table"}. According to the sensitivity analysis results using this data, the LOD and LOQ were calculated as 40 ag/μL (1.2 × 10^1^ genome copies/μL) and 400 ag/μL (1.2 × 10^2^ genome copies/μL), respectively ([Table 5](#pone.0229561.t005){ref-type="table"}). The quantitative analysis results for *Aspergillus* gDNA and positive control DNA showed similar correlations and regression coefficients for all probes.

![Sensitivity measurements of *Aspergillus* gDNA and quantification curve.\
*Aspergillus* gDNA and *Aspergillus* positive-control DNA were subjected to multiplex real-time PCR using Fumi 1R2, Nigri 1R26, Flavi 1F18, Terrei 1R29, Asco 1F9 and the results were presented as a standard curve. The spot is the average of Cq ± SD and n = 6. Abbreviations. gDNA; genomic DNA, SD; Standard Deviation.](pone.0229561.g001){#pone.0229561.g001}

10.1371/journal.pone.0229561.t004

###### Correlation and regression analysis between two DNA.

![](pone.0229561.t004){#pone.0229561.t004g}

  Probe name   Genomic DNA             Control DNA                                                               
  ------------ ----------------------- ------------- --------- -------- ----------------------- ------ --------- --------
  Fumi_1R2     21.1 \~ 38.6 (± 0.39)   92.2          -3.5245   0.9993   21.5 \~ 38.6 (± 0.20)   90.1   -3.5844   0.9998
  Nig_1R26     21.0 \~ 39.6 (± 0.20)   89.8          -3.5930   0.9983   21.1 \~ 39.1 (± 0.31)   90.0   -3.5866   0.997
  Flavi_1F18   20.9 \~ 37.4 (± 0.55)   92.6          -3.5132   0.9995   21.9 \~ 39.1 (± 0.74)   94.0   -3.4755   0.999
  Ter_1R29     20.9 \~ 37.0 (± 0.62)   104.8         -3.2119   0.9998   21.1 \~ 38.9 (± 0.73)   92.5   -3.5168   0.9978
  Asco_1F9     21.0 \~ 37.6 (± 0.87)   103.5         -3.2412   0.9979   22.0 \~ 38.5 (± 0.13)   99.4   -3.3373   0.9975

^†^E: Efficiency

10.1371/journal.pone.0229561.t005

###### Correlation and regression analysis between two DNA.
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  gDNA / control DNA   Fumi 1R2        Nig 1R26        Flavi 1F18      Ter 1R29        Asco 1F9
  -------------------- --------------- --------------- --------------- --------------- ---------------
  4 ng / 4 pg          21.07 / 21.50   21.01 / 20.12   20.94 / 21.92   20.98 / 21.20   20.93 / 22.08
  400 pg / 400 fg      24.30 / 25.21   25.21 / 24.41   24.59 / 25.00   24.31 / 24.41   24.50 / 25.45
  40 pg / 40 fg        28.34 / 29.01   29.17 / 28.70   28.07 / 28.42   27.41 / 27.26   27.88 / 28.15
  4 pg / 4 fg          31.65 / 32.55   32.53 / 32.00   31.41 / 32.41   30.79 / 30.54   30.83 / 31.37
  400 fg / 400 ag      35.05 / 36.23   36.47 / 36.06   35.29 / 35.58   33.94 / 33.58   33.59 / 34.57
  40 fg / 40 ag        38.64 / 39.69   39.65 / 39.12   38.44 / 39.10   37.01 / 36.95   37.64 / 36.52

Sensitivity measurement for molecular identification method by culture time {#sec012}
---------------------------------------------------------------------------

Four reference strains were used to measure the fungal colony diameter over the culture time. The size of *A*. *fumigatus*, *A*. *niger*, *A*. *terreus*, and *A*. *flavus* colonies was 0.2--1.5 cm at 18--24 h after incubation, 1.4--5.2 cm after 48 h, and 4.0--7.8 cm after 72 h. Further, conidia formation was observed after 72 h. Multiplex real-time PCR using DNA extracted from early-stage colonies showed successful amplification in hyphae-state after culturing for 24 h. The minimum colony diameter to confirm colony DNA amplification in all probes was 0.4 cm (confidence interval, CI \> 95%), and the minimum culture time was 18--24 h. The result of multiplex real-time PCR of DNA from hyphae-state colonies of 0.4 cm in diameter for all isolates showed Cq values of 31.425 ± 0.245 for *A*. *fumigatus*, 32.345 ± 0.185 for *A*. *niger*, 32.63 ± 0.36 for *A*. *terreus*, and 32.16 ± 0.12 for *A*. *flavus*. This suggested that amplification occurred within the range of the standard curve of *Aspergillus* positive control DNA used as standard DNA, which is between approximately 1.0--1.2 × 10^2^ and 1.0--1.2 × 10^1^ copies/μL when calculated with respect to genomic DNA copy number.

Inhibition {#sec013}
==========

Each of the DNA extracts material was included in a SPUD assay and results indicated that no inhibition was present in gDNA samples ([S3 Fig](#pone.0229561.s003){ref-type="supplementary-material"}).

Discussion {#sec014}
==========

In this study, a molecular identification method for major *Aspergillus* sections (*Fumigati*, *Nigri*, *Flavi*, and *Terrei*) and filamentous ascomycetes were developed based on the *benA* gene, which reduced diagnosis time compared with the current methods of morphological or molecular identification based on ITS sequencing. Also, probe-based real time PCR can more sensitive, specific, fast, and used in a quantitative than multiplex PCR. For this reason, probe-based real time PCR was used in the design. In addition, TR mutation and the *cyp51A* gene were used to identify azole-resistant *A*. *fumigatus* and *A*. *tubingensis*. Instead of probe-based sequencing, melting temperature analysis methods were selected for faster and simultaneous analysis. The designed probes and primers were used for qualitative and quantitative analyses of 118 clinical and environmental isolates. Sensitivity and specificity were evaluated for the developed multiplex real-time PCR method. Further, both LOD and LOQ with minimum culture time were analyzed to evaluate to the applicability of the method for early diagnosis.

For the molecular identification of mold, there is a need to improve the process and purity of DNA extraction. Extracted DNA quality and impurity contents, such as PCR inhibitors, differ between each clinical and environmental isolate; thus, it is difficult to conduct quantitative measurements and evaluate the sensitivity of molecular identification. In this study, we optimized methods to extract mold (filamentous fungal) DNA. We did lysis of clinical and environmental mold using enzyme and Qiagen purification kit. However, their purity was not good for quantitative analysis, and many variables among species and strains. So, we tried to look for the efficient lysis and complete removal of protein and PCR inhibitors, and then it has been tested in hundreds of mold strains. First, freeze-thawing and bead-beating methods were used for mechanical lysis, and different lysis and protein removal solutions were used for the conidia and hyphae (hyphae, Trizol solution and isopropanol; conidia, Epicentre's lysis buffer and protein precipitation solution). Some researchers suggested bead beating could be more efficient at lysing fungus than enzymatic lysis \[[@pone.0229561.ref021]\]. And, Trizol reagent (Invitrogen) led to a better yield in the hyphae, but affected the purity in conidia as the handling process during supernatant isolation and showed the incomplete lysis in conidia of some strain. Therefore, we performed lysis conidia using different lysis buffers. In the purification process, the most commonly used method was column chromatography for final purification, and high-purity fungal DNA was obtained in almost all strains. For accurate quantification, Quant-iT^™^ PicoGreen^™^ dsDNA Reagent (Invitrogen) was used, which has a lower error rate compared with conventional OD methods and offers advantages in quantitative analysis and sensitivity measurements.

To establish a multiplex real-time PCR method with high specificity and sensitivity, *benA* and *cyp51A* were used to select a primer pair and probe specific to the major *Aspergillus* sections, and *benA* has been used as an important molecular marker to analyze the phylogenic relationship between filamentous ascomycetes \[[@pone.0229561.ref005], [@pone.0229561.ref022]\]. The genetic analysis of *benA* is useful to distinguish cryptic species, which is not possible with ITS sequencing. Although there are differences between species, approximately 560 bp (bt2ab region: exons 3−6) can be amplified for nucleotide sequence analysis. However, in this study, the region was designed to be shorter (exons 5−6) to be more suitable for the multiplex probe-based real-time PCR method, which improved efficiency while maintaining specificity ([S1 Fig](#pone.0229561.s001){ref-type="supplementary-material"}, [Table 1](#pone.0229561.t001){ref-type="table"}). While developing a probe-based method for rapid simultaneous detection, we also designed *benA* primers for further sequence analysis to achieve specificity toward each species after amplification/probe detection. This could specifically amplify certain *Aspergillus* sections through multiplex real-time PCR, reflecting high specificity without cross-amplification of other fungal species. Further, quantification analysis of each probe showed an extremely small error rate, and approximately 10^1^ genomic copies could be detected, indicating high sensitivity. These results show that the developed method have similar sensitivity to existing methods used for detection and quantification analysis \[[@pone.0229561.ref004], [@pone.0229561.ref019]\].

Regarding the use of standard DNA as a control for a developed method, gDNA usage for each *Aspergillus* strain is complex and requires much time; furthermore, many standard DNA types for specific probes are needed. Therefore, in this study, synthetic DNA was designed and used as standard DNA that reacted with all probes. The developed *Aspergillus* positive control DNA was amplified in all *benA* probes that identified different *Aspergillus* sections. Further, reconstructed *Aspergillus* positive control DNA for quantitative analysis was used to compare analyses with a standard curve, which correlated with the standard gDNA curve ([Table 5](#pone.0229561.t005){ref-type="table"}). These results indicate that this DNA can be used as the control for sample gDNA quantification, to verify the primers and probe used in the experiment, and to measure experimental sensitivity and specificity. Also, use of multiple control DNAs complicates the experiment and can increase the cost of diagnostics by using multiple wells. To solve this problem, control DNA was synthesized and used. The synthetic DNA could be applied with the newly designed *benA* probe in the field for IA diagnosis.

Among the sections amplified in the first stage, azole resistance in *A*. *fumigatus* and *A*. *tubingensis* of section *Nigri* can be detected using multiplex real-time PCR primer/probes designed in the second stage. Using isolates from *Aspergillus* section *Fumigati*, the melting peak and temperature were identified for the primers that specifically amplified the *cyp51A* TR region in *A*. *fumigatus* and gDNA subjected to a 10-fold serial dilution. Wild-type isolates and mutant isolates with TR34 showed different melting temperatures. In particular, *A*. *tubingensis* revealed intrinsically higher azole minimum inhibitory concentrations according to previous studies \[[@pone.0229561.ref002], [@pone.0229561.ref003], [@pone.0229561.ref005]\]. The *A*. *tubingensis*-specific primers and probe designed in this study showed that only *A*. *tubingensis* was amplified without affecting other *Aspergillus* in section *Nigri*.

Interestingly, we tried to use DNA extracted from early-stage fungal colonies for PCR analysis and determined that the minimum diameter and culture time required for successful PCR detection were 0.4 cm and 24 h, respectively. The same results were obtained for four probes, suggesting that fungal colony hyphae cultured for 24 h can be used for earlier molecular identification. Although there may be some limitations in early diagnosis, our developed method can dramatically reduce the minimum culture period for molecular identification within 2--3 days. In other words, it has been reduced by 3 to 14 days compared to the previous method.

In conclusion, first, newly designed primers and probes were used to conduct a multiplex real-time PCR assay, and high sensitivity and specificity was confirmed through clinical and environmental fungal isolates. Second, azole-resistant *A*. *fumigatus* and *A*. *tubingensis* were detected, and major *Aspergillus* sections were identified. Third, this real-time PCR method resulted in successful amplification specific to each section with DNA extracted from *Aspergillus* hyphae in the early phases of the cultured colony. This method can provide a template for rapid and quantitative diagnosis of IA. Fourth, *Aspergillus* positive control DNA designed for the standard control permitted quantitative analysis. It is expected that further research on new biomarkers will be conducted using the database obtained through this study. And we will approach the LOQ and LOD both in fungal DNA extraction and multiplex real time PCR from clinical specimens for clinical use in further study.

Supporting information {#sec015}
======================

###### Probe and primer design by sequence comparison analysis of major *Aspergillus* species.

The MegAlign Pro program from DNAStar Lasergene (version 15 software package) was used to compare the sequence analysis by using Clustal Omega alignment. The comparison of *benA* sequences in *Aspergillus* species. All *benA* sequences in *Aspergillus* were compared and regions specific to the section without affecting other sections were selected as probe candidates, and primers that included all selected regions were chosen. Finally, one pair of primers and five probes were selected.

(TIF)

###### 

Click here for additional data file.

###### Analysis of melting peak for two types of *Aspergillus fumigatus* showing different azole resistance.

Wild-type (WT) isolate without azole resistance in *A*. *fumigatus* and azole-resistant isolate with TR34 sequence were used in the experiment. A pair of primers that amplified the region in the *cyp51A* promotor known to be involved in azole resistance was used for the melting peak analysis. DNA was subjected to a 10-fold dilution (4 ng to 40 fg). The melting temperatures from the melting curve analysis were different: 83.0ºC ± 0.3ºC in WT and 85.6ºC ± 0.6ºC in azole-resistant type (n = 3).

(TIF)

###### 

Click here for additional data file.

###### SPUD analysis of SPUD plasmid DNA and genomic DNA.

Quantitative PCR was performed using positive control SPUD plasmid DNA (1.3 × 105 copies / μL, n = 20) and various genomic DNAs containing the same amount of SPUD (n = 70), and the results were plotted on a box plot. It can be seen that the Cq value between the two DNAs varies within 1 cycle. The experiment repeated three times.

(JPG)

###### 

Click here for additional data file.

###### Non-Aspergillus species used for negative control in qualitative analysis.

(DOCX)

###### 

Click here for additional data file.
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2\. Has the statistical analysis been performed appropriately and rigorously?
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5\. Review Comments to the Author

Reviewer \#1:

1\. What are the novelties of your work compared to other studies using \"multiplex real time PCR\" for Aspergillus detection like: \"Multiplex real-time PCR for detection and quantification of mycotoxigenic Aspergillus, Penicillium and Fusarium\" 2009. Journal of Stored Products Research.

2\. Lines 56-58, Introduction part: -These steps are shared between your method and \"identification via the polymerase chain reaction\" methods. - What are the merits of your method compared to other molecular methods such as multiplex PCR?

3\. Line 215, discussion part: In average, how much time was reduced compared to other methods?

Reviewer \#2:

The manuscript is relevant for PlosOne but there are some issues. You have a very good results but I would like that you explain more about material and methods used to synthesize the control DNA. When you explain about the standard curve, never show the efficiency (E). However in M&M is explianed that it has been calcualted.

Reviewer \#3:

1-DNA extraction and purification

Authors indicated: " In this study, we optimized methods to extract mold DNA. First, freeze-thawing and bead-beating methods were used for mechanical lysis, and different lysis and protein removal solutions were used for the conidia and hyphae (hyphae, Trizol solution and isopropanol; conidia, Epicentre's lysis buffer and protein precipitation solution). Different lysis buffers were used because Trizol reagent".

Please, for this issue referr to previous validations of fungal DNA extraction, where it was shown that columns and magnetic beads allowed collecting DNA and separate PCR inhibitors, but detection rates could not be related to DNA-avidity of beads or to elution but to the lack of proteolysis.

Please refer to:

-Goldschmidt P, Degorge S, Merabet L, Chaumeil C. Enzymatic treatment of specimens before DNA extraction directly influences molecular detection of infectious agents. PLoS One. 2014 Jun 17;9(6):e94886. doi:10.1371/journal.pone.0094886.)

-Hsu M, Chen K, Lo H, Chen Y, Liao M, et al. (2003) Species identification of medically important fungi by use of realtime LightCycler PCR. J. Med. Microbiol 52: 1071--1076.

2- As for potential clinical use it should be stressed that the yields of DNA extraction and the PCR inhibitors must be monitored (i.e. by adding internal controls to each sample). results of the systematic validation of this issue were not found in the manuscript.

3- Resutls of LOQ and LOD were 40 fg and 400 fg, respectively. Here, in addition to the quantitative analysis expressed as DNA mass (pg, fg, etc), the sensitivity of the test for each sample should be also related to the number of colony forming units.

For further clinical use, the detection limits should be be also compared with fresh titrated fungal suspensions seeded into the haemoculture system (inoculums containing serial diluted CFU/bottle).

Please, refer to:

-Obara H, Aikawa N, Hasegawa N, Hori S, Ikeda Y, et al. (2011) The role of a real-time PCR technology for rapid detection and identification of bacterial and fungal pathogens in whole-blood samples. J Infect Chemother 3: 327--33.

-Goldschmidt P, Degorge S, Che Sarria P, Benallaoua D, Semoun O, Borderie V, Laroche L, Chaumeil C. New strategy for rapid diagnosis and characterization of fungal infections: the example of corneal scrapings. PLoS One. 2012;7(7):e37660.)

4- Results of specificity of the different set of primers with no filamentous fungi were not found.

-Marr KA, Carter R, Crippa F, Wald A, Corey L (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34: 909--17.

-Horvath L, George B, Murray C, Harrison L, Hospenthal D (2004) Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J Clin Microbiol 42: 115--8.
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\- We made further edits in response to the editor\'s comments. The revised version was corrected by the style of the journal, and modified parts were given in highlight.

2\. Thank you for stating the following financial disclosure:

\"This research was supported by an industry-university research grant (5-2019-D0166-00004) through the Yuhan Corporation.\"

We note that one or more of the authors have an affiliation to the commercial funders of this research study : \[Yuhan Corporation.\].

1\) Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors\' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

\* Please also include the following statement within your amended Funding Statement.

"The funder provided support in the form of salaries for authors \[insert relevant initials\], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."
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Review Comments to the Author

Reviewer \#1:

1\. What are the novelties of your work compared to other studies using \"multiplex real time PCR\" for Aspergillus detection like: \"Multiplex real-time PCR for detection and quantification of mycotoxigenic Aspergillus, Penicillium and Fusarium\" 2009. Journal of Stored Products Research.

: I appreciate that you reviewed our paper in detail. In this study, our strategy for the molecular detection of Aspergillus focused on the diagnostics of the invasive aspergillosis (IA). Due to the high morbidity and mortality of IA, the rapid detection and identification are very important in the clinical setting. Aspergillus fumigatus, A. niger, A. flavus, and A. terreus have been reported as the significant species isolated in IA. Our designed probe can be specifically and sensitively to the major species of IA (A. fumigatus, A. niger, A. flavus, and A. terreus), in addition to the filamentous ascomycetes. Also, our work additionally detects to azole-resistant A. fumigatus and A. tubingensis of which strains have high MIC to azole comparing to other Aspergillus species. Taken together, our work could be used as the rapid identification and azole resistance in the diagnostic of IA, compared to other studies. In Discussion part, we discussed it in the revised version (line 297-302 ).

2\. Lines 56-58, Introduction part: -These steps are shared between your method and \"identification via the polymerase chain reaction\" methods. - What are the merits of your method compared to other molecular methods such as multiplex PCR?

: As you commented, "molecular identification is limited" should be unclear. We intended to improve the limitations of current time-consuming filamentous fungal identification by sequencing-based methods. Therefore, it is modified as "sequencing-based identification is time-consuming" (line 54-55).

Compared to multiplex PCR, our method has the advantages of the probe-based real time PCR, so it can be more sensitive, more specific, faster, and used in a quantitative method. Also, our probe-based method could be a time effective way because it does not need additional time for the sequencing (line 233-235 in the section Discussion).

3\. Line 215, discussion part: In average, how much time was reduced compared to other methods?

: It usually takes 3-14 days of fungal culture for conidia production (Different culture time for each clinical strains), 2-3 days for PCR & sequencing, and 2-3 days for azole-resistant MIC analysis. Therefore, on average, it takes 7 to 20 days. However, in this study, we increased sensitivity and detected in the early stages of hyphae generation, and we performed probe-based real time PCR that did not perform sequencing. As a result, the time required for diagnosis after culture was reduced to 2 \~ 3 days. In other words, it has been reduced by 3 to 14 days compared to the previous method.

This has been modified in the introduction (line 54-57) and discussion (line 294-296).

 

Reviewer \#2:

The manuscript is relevant for PlosOne but there are some issues. You have a very good results but I would like that you explain more about material and methods used to synthesize the control DNA.

When you explain about the standard curve, never show the efficiency (E). However in M&M is explianed that it has been calcualted.

Line 127: What is the protocol used to synthesized the control DNA?

: I appreciate that you reviewed our paper in detail.

As you commented, our explanation could be insufficient. So we described more in materials and methods (lines 124-131) as below.

At first, we aligned each consensus sequence of benA in Aspergillus species (S1 Fig). We used benA sequence of A. fumigatus as the template and designed to have each probe sequence (conserved probe of filamentous ascomycetes, Fumigati, Nigri, Flavi, and Terrei) (Table 2). And then, the designed DNA was synthesized genetically (Bionics Corporation, Seoul). We cloned it into the pUC57 plasmid, and it was transformed into Escherichia coli BL21strain. Plasmid DNA of transformants was extracted, tested for the multiplex, and used as control DNA.

Line 130: why has the author synthesized a control DNA instead to clon different fragments of DNA as positives controls?

: If different fragments are used as controls, several control-set should be needed. More controls need more wells. In clinical settings, more control leads to fewer test samples, especially in quantitative analysis. Therefore we designed a synthesized control including all probes (5 probes). We describe it at the section of Material & Method and Discussion (line 124-131, line 279-281).

Results: Line 167: delete a \"were not\"

: I thank you for reviewing in detail. We had been corrected it (line 177-178).

Line 188: The author should include the Efficiency (%) calculated, as explianed in M&M, to each standard curve.

: As you commented, we added efficiency (%) in the revised version. The amplification efficiency of each probe was found to be 89.8% \~ 104.8% in gDNA and 90.0% \~ 99.4% in Control DNA. These results are described in the line 192-193 of the results section, and each value is added in Table 5.

 

Reviewer \#3:

1-DNA extraction and purification

Authors indicated: " In this study, we optimized methods to extract mold DNA. First, freeze-thawing and bead-beating methods were used for mechanical lysis, and different lysis and protein removal solutions were used for the conidia and hyphae (hyphae, Trizol solution and isopropanol; conidia, Epicentre's lysis buffer and protein precipitation solution). Different lysis buffers were used because Trizol reagent".

Please, for this issue referr to previous validations of fungal DNA extraction, where it was shown that columns and magnetic beads allowed collecting DNA and separate PCR inhibitors, but detection rates could not be related to DNA-avidity of beads or to elution but to the lack of proteolysis.

Please refer to:

-Goldschmidt P, Degorge S, Merabet L, Chaumeil C. Enzymatic treatment of specimens before DNA extraction directly influences molecular detection of infectious agents. PLoS One. 2014 Jun 17;9(6):e94886. doi:10.1371/journal.pone.0094886.)

-Hsu M, Chen K, Lo H, Chen Y, Liao M, et al. (2003) Species identification of medically important fungi by use of realtime LightCycler PCR. J. Med. Microbiol 52: 1071--1076.

: I appreciate that you reviewed our paper in detail.

We reviewed the two papers which you referred to. Both papers showed better removal of PCR inhibitors using lyticase and protease K. In these papers you mentioned, only a few strains of filamentous fungus (mold) were tested. We did lysis of clinical and environmental mold using enzyme and Qiagen purification kit. However, their purity was not good for quantitative analysis, and many variables among species and strains. So, we tried to look for the efficient lysis and complete removal of protein and PCR inhibitors, and then it has been tested in hundreds of mold strains.

We used a bead beating lysis method using Trizol reagent (invitrogen) in the case of hyphae and lysis solution of MasterPure ™ Yeast DNA Purification Kit (Epicentre) in conidias. In addition, we performed purification using phenol/chloroform or precipitation buffer (kit), and then they were additionally purified by the column kit (Qiagen). In tested mold strains, these methods performed complete physical lysis and a fungal DNA purification with the high purity for the quantitative analysis. Trizol agent is more economical and effective in hyphae, but it showed the incomplete lysis in conidia of some strain. The lysis solution of the kit showed the complete lysis and removal of PCR inhibitor in both hyphae and conidia.

Some researchers suggested bead beating could be more efficient at lysing fungus than enzymatic lysis (EAPCRI method for Aspergillus DNA from whole blood) (Rosemary A Barnes, P Lewis White, C Oliver Morton, Thomas R Rogers, Mario Cruciani, Juergen Loeffler, J Peter Donnelly, Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips. Medical Mycology 2018 56(suppl_1):60-72. <https://doi.org/10.1093/mmy/myx091>).

We discussed it in the Discussion part (line 241-257)

2- As for potential clinical use it should be stressed that the yields of DNA extraction and the PCR inhibitors must be monitored (i.e. by adding internal controls to each sample). results of the systematic validation of this issue were not found in the manuscript.

: Actually, we monitored of PCR inhibitors using SPUD plasmid DNA (insert in pUC57 vector) as an internal control. It is a routine task and I did not write it in the paper. However, I regret that it was not mentioned in the first version of our paper. We add the monitoring results in the revised version.

We performed an experiment to determine the presence of a PCR inhibitor. In the real time PCR process, the experiment was conducted by spiking SPUD DNA with a 1.3 X 105 copy number. When the difference of Cq value was \<1 compared to the SPUD DNA diluted in PBS, it was determined that there was no PCR inhibitor. Also, we checked the yields of DNA extraction by monitoring the mass of genomic DNA. When fungal DNA was extracted in \~108 of conidia, and the amount is \>3.5μg (usually 4-5 μg) measured by Quant-iT™ PicoGreen™ dsDNA Reagent (Invitrogen), we used it in our study (the mass of one genome copy of Aspergillus was calculated to around 40 fg). We described it in the section of Material and Method and Result. (S3 Fig, line 159-166, 226-228).

3- Resutls of LOQ and LOD were 40 fg and 400 fg, respectively. Here, in addition to the quantitative analysis expressed as DNA mass (pg, fg, etc), the sensitivity of the test for each sample should be also related to the number of colony forming units.

For further clinical use, the detection limits should be be also compared with fresh titrated fungal suspensions seeded into the haemoculture system (inoculums containing serial diluted CFU/bottle).

Please, refer to:

-Obara H, Aikawa N, Hasegawa N, Hori S, Ikeda Y, et al. (2011) The role of a real-time PCR technology for rapid detection and identification of bacterial and fungal pathogens in whole-blood samples. J Infect Chemother 3: 327--33.

-Goldschmidt P, Degorge S, Che Sarria P, Benallaoua D, Semoun O, Borderie V, Laroche L, Chaumeil C. New strategy for rapid diagnosis and characterization of fungal infections: the example of corneal scrapings. PLoS One. 2012;7(7):e37660.)

: As you mentioned, it could be a better way to describe the sensitivity related to the number of colony-forming units (CFU). However, CFU of the filamentous fungus (mold) is difficult to be counted due to the existence of hyphae and conidia (live/dead), the different growth rates of each conidia, error rate of hemocytometer counting, and so on. Therefore, the quantitative analysis from CFU of mold is very variable, and the validation should be difficult. We decided to validate our method by DNA mass related to fungal genome copy. Although the graphs and graphs are the mass of DNA (pg, fg), the genome copies number was obtained using the genome size and molar concentration, and we described in the text (Fig 1, Line 193-197, 220-224).

Therefore, we statistically described multiplex real time PCR results of LOQ and LOD in this paper, not the method of fungal DNA extraction. As you mentioned, we will approach the LOQ and LOD both in fungal DNA extraction and multiplex real time PCR from clinical specimens for clinical use in further study.

We will discuss it in the section of Discussion (line 304-305).

4- Results of specificity of the different set of primers with no filamentous fungi were not found.

-Marr KA, Carter R, Crippa F, Wald A, Corey L (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34: 909--17.

-Horvath L, George B, Murray C, Harrison L, Hospenthal D (2004) Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J Clin Microbiol 42: 115--8.

: We designed a probe able to detect filamentous ascomycetes. Besides, non-ascomycetes and non-filamentous ascomycetes were used in the specificity of the test, and these results were described (Line 171-173). In one of non-filamentous ascomycetes (No. 39, Table S1), and 8 of non-ascomycetes molds (No. 40-47, Table S1), there was no cross-reaction in all set of probes. In the designed real time PCR in this study, the fungal DNA of filamentous ascomycetes (No. 1-38, Table S1) was amplified specifically. (Table 3, Table S1)
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Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.
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